Most Recent
The maker of Mother energy drinks has won an appeal of an IP Australia decision, succeeding in its bid to prevent a Victoria-based company from registering Kangaroo Mother as a trade mark for beverages.
Novartis has lost its bid to have Pharmacor’s claim that its patent for a blood pressure drug is invalid decided ahead of a main trial where the Swiss pharmaceutical giant will allege the generic drug maker is threatening to infringe its patent.
A judge has upheld findings from IP Australia that South Korean biotech ToolGen's genome editing technology CRISPR is not patentable, but given the company one more chance to seek to amend its application.
Retail giant Cotton On has hit back at allegations of copyright infringement, highlighting the prevalence of copying in the fashion industry.
The Full Federal Court has upheld US biotech company Sequenom's patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic's argument that the patent merely described a way to extract incorporeal genetic information.
Juno Pharmaceuticals has backed away from its plans to launch a generic version of HIV drug Prezista in Australia after being hit with a patent lawsuit by Janssen, becoming the second generic drug maker to capitulate to the Johnson & Johnson-owned company's demands.
The High Court has declined to take up Mylan's challenge to a Full Court ruling upholding the invalidity of three patents for its blockbuster cholesterol drug Lipidil.
Women's fashion designer Pinnacle Runway must pay indemnity costs for pursuing what a judge has described as an "ill-advised" trade mark infringement lawsuit against a rival that "cried out to be settled".
Tile maker Ceramiche Caesar has prevailed in its challenge to a judge's ruling allowing building products manufacturer Caesarstone to register two trade marks despite a finding that they were deceptively similar to one of its marks.
Mylan Health has lost its challenge to a ruling that invalidated three patents related to its blockbuster cholesterol drug Lipidil, despite the appeals court finding the primary judge had erred by ruling that proof of intention was required for Swiss-style claims.